← FDA Drug Approvals (Drugs@FDA)

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2009-11-16

Drug application

FDA Application #

ANDA040885

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Generic name

BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE

Active ingredients

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

LGM PHARMA

Manufacturer

Actavis Pharma, Inc.

First approval

2009-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown